Resources

23 Resources for

drug company and jim edwards

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

NEJM: Foreign Drug Trials Could Hurt U.S. Patients
The increasing use of foreign drug trials may hurt U.S. patients because of genetic and environmental differences in overseas study subjects, a new study in the New England Journal of Medicine suggests. "Are trial results accurate and valid, and can they be extrapolated to other settings?" asks a team from...
Tags: U.S., China, India, Patient, Vaccine, Pfizer Inc., Drug Company, Clinical Trial, Trial, Argentine Authority, GSK, Healthcare, Jim Edwards
Blog posts 2009-02-19
FDA Seeks Advice From Blogger; Google Solves Pharma's Ad Problems
The FDA sought the advice of John Mack, a blogger with 20,000 monthly readers who runs the Pharma Marketing Blog, on how drug companies should use the web to advertise their products. The agency usually likes to hear from lawyers, drug company executives and academics when it seeks regulatory advice....
Tags: Google Inc., FDA, Advertisement, Advice, Drug Company, Pharmaceutical Company, Blogger, Federal Government, Government, Jim Edwards
Blog posts 2009-11-12
In Q2, Drug Companies Lobbied to Expand Many Government Healthcare Programs
A look at what drug companies spent on lobbying in the second quarter of 2009 shows an interesting dichotomoy: It's a parade of selfishness that, if successful, may end up doing more to expand government-run healthcare in the U.S. than President Obama's reforms. by Jim Edwards
Tags: Drug Company, Health Care, Vertical Industries, Government, Benefits, Healthcare, Human Resources, Jim Edwards
Blog posts 2009-09-01
Ranking of 20 Drug Companies Shows Sales Force Effectiveness Reaching Plateau
A ranking of 20 drug companies by sales and marketing productivity shows that 10 companies saw upward trends in effectiveness in Q2 2009. Last quarter, 13 companies had upward trends. The numbers indicate that companies have started to reach a plateau in their efforts to wring more revenues out of...
Tags: Sales Force, Drug Company, Sales Strategy, Sales Force Management, Marketing Research, Sales, Marketing, Jim Edwards
Blog posts 2009-08-07
Schuler Takes Seat at Elan; Icahn Lurks in the Wings; Bad News on Tysabri
Things are moving quickly at Elan, the illogically managed Irish drug company whose top executives work in at least three different offices that are 5,000 miles apart. by Jim Edwards
Tags: Top Executive, Drug Company, Schuler, Jim Edwards
Blog posts 2009-06-12
Insomnia Pill Makers Go After Elderly With New 'Fear of Falling'
For years, drug companies have tried to expand the range of prescriptions of sleeping pills. They're not just for sleeping any more -- now they're also for avoiding "rebound insomnia" in the elderly, "increased risk of automotive crashes, decreased work performance ... or mood changes," generalized anxiety disorder, and depression....
Tags: Sleep, Women, Drug Company, Sepracor Inc., Neurocrine Biosciences Inc., Gender And Diversity, Human Resources, Jim Edwards
Blog posts 2008-09-11
GSK and Others See Massachusetts Showdown Over Drug-Marketing Reform
There are two ideas floating in the world of politics to curb the way drug companies give doctors gifts and often biased information. One of them is a good idea, and one of them is a bad idea. Drug companies -- such as GlaxoSmithKline -- have chosen...
Tags: Drug Company, Idea, Massachusetts, U.S. Senate, GSK, Government, Sales Force Management, Vertical Industries, Sales, Enterprise Software, Software, Jim Edwards
Blog posts 2008-08-08
Johns Hopkins in Pharma Funding Flap
Is Johns Hopkins University Medical School offering to endorse drug company "educational" materials for money? That was the allegation made last week by Daniel Carlat, a blogger and psychiatrist in private practice. Johns Hopkins, naturally, denies the claim. Carlat says Johns Hopkins is offering...
Tags: Certification, Drug Company, Pharmaceutical Company, Carlat, CME, CME Event, Quality, Business Operations, Jim Edwards
Blog posts 2008-08-05
BNET Focus on Antidepressants: Part 2, Controversies
While the antidepressant market is both robust and lucrative, as we saw in part 1 of this three-part series, it is also controversial. No drug category is so dogged by doubts and questions, and yet so widely prescribed, as antidepressants. The most recent major event in the...
Tags: FDA, Drug Company, Suicide, Drug, Comments Section, Senate Finance Committee, Federal Government, Government, Jim Edwards
Blog posts 2008-10-01
Drug Companies' Health Education Campaigns No Longer Speak Spanish
For the first time in at least three years, drug companies have spent zero dollars on Spanish-language television for their unbranded health education ads, Nielsen-Monitor Plus reports. The wholescale write-off of Hispanic TV draws attention to how little Spanish-language provision there is in drug marketing. Of the...
Tags: Education, Advertisement, Amgen Inc., Drug Company, Health Care, Vertical Industries, Benefits, Healthcare, Web Site Development, Channel Management, Enterprise Software, Software, Human Resources, Internet, Marketing, Jim Edwards
Blog posts 2008-10-03
Why Drug Companies Prefer Twitter Over Blogs
GlaxoSmithKline has started a blog, becoming only the fourth* major drug company to launch an official unofficial voice on the web. by Jim Edwards
Tags: Drug Company, Blog, Twitter, Blogging, Internet, Jim Edwards
Blog posts 2009-05-19
Ranking of 20 Drug Companies by Sales Force Effectiveness Shows Improvement in Q1
A ranking of 20 drug companies on sales and marketing productivity shows upward trends in effectiveness in Q1 2009. At the top of the table is AIDS drug specialist Gilead. At the bottom of the table is vanity pharma play Medicis. by Jim Edwards
Tags: Sales Force, Drug Company, Sales Strategy, Sales Force Management, Marketing Research, Sales, Marketing, Jim Edwards
Blog posts 2009-05-14
Wyeth v. Levine's Unintended Consequences: Prescription Data-Mining Banned in Vermont
A federal court in Vermont has upheld a law preventing drug companies from "data-mining" prescription information from pharmacies. The court cited the U.S. Supreme Court's Wyeth v. Levine anti-preemption ruling as one of its reasons in doing so, suggesting that the Wyeth decision will consequences far beyond personal injury class-actions....
Tags: Wyeth, Drug Company, Vermont, Levine, Data Mining, Business Intelligence, Marketing Research, Databases, Enterprise Software, Software, Data Management, Marketing, Jim Edwards
Blog posts 2009-04-27
14 Drug Companies Cited for Misleading Google Ads
The FDA cited 14 drug companies for misleading advertising in sponsored ads among Google search results. Those cited: Biogen Idec, Sanofi Aventis, GlaxoSmithKline, Forest Laboratories, Cephalon, Bayer, Johnson & Johnson, Pfizer, Novartis , Genentech, Boehringer Ingelheim, Merck, Hoffman-LaRoche, and Eli Lilly. The citations, sent...
Tags: Google Inc., Bayer AG, FDA, Advertisement, Drug Company, Sanofi-Aventis, Federal Government, Government, Jim Edwards
Blog posts 2009-04-07
Tafas v. Doll: Drug Companies Face New Limits on Patents
Drug companies will be dismayed by a federal appeals court ruling that came down on Friday which gives the U.S. Patent and Trademark Office new powers to limit the way patents are filed. The drug business depends heavily on its ability to patent chemicals and processes for...
Tags: Patent, Drug Company, Rule, Drug Business, Jim Edwards
Blog posts 2009-03-23
NPR Producer: Goodwin Broke "Ironclad" Contract Over GSK Cash; Pitts Didn't Disclose Ties
The producer of an NPR radio show has accused the show's host, Fred Goodwin, of breaking his contract by failing to disclose his ties to drug companies. The producer also denies that Peter Pitts, a former FDA official and an executive at Manning, Selvage & Lee, a...
Tags: Drug Company, NPR, Radio, Pharmaceutical Company, Tie, Satellite Radio, Federal Government, Advertising & Promotion, Public Relations, Consumer Electronics, Personal Technology, Government, Marketing, Corporate Communications, Jim Edwards
Blog posts 2009-03-09
Ranking of 20 Drug Companies' Sales Forces Shows Productivity Flat or Declining
A ranking of drug company sales productivity shows Gilead gets the most revenues in return for every dollar invested in reps and marketing. At the other end of the table, Sepracor gets the least bang for its sales, general and administrative buck see table below. ...
Tags: Revenue, Pfizer Inc., Sales Force, Drug Company, Genentech Inc., Sepracor Inc., Sales Strategy, Sales Force Management, Operational Accounting, Sales, Finance, Jim Edwards
Blog posts 2009-02-24
Novartis, Boehringer Start Using Twitter Accounts
AstraZeneca, Novartis, Vertex Pharmaceuticals and Boehringer Ingelheim have started experimenting with Twitter with varying degrees of enthusiasm, reports Pharmaceutical Executive. Drug companies have so far looked at social media with a mixture of fear and loathing. They believe perhaps wrongly that giving consumers more opportunities to talk...
Tags: Drug Company, Social Media, Novartis AG, Pharmaceutical Company, Twitter, AZ, BI Site, Pricing, Business Intelligence, Tools & Techniques, Marketing, Enterprise Software, Software, Data Management, Management, Jim Edwards
Blog posts 2009-02-18
FDA to Allow "Off-Label" Unapproved Drug Promotion
The FDA has "finalized" guidelines allowing drug companies to promote drugs for unapproved ("off-label") uses. The guidelines will allow companies to distribute  peer-reviewed scientific literature discussing off-label uses. Drug companies and their right-wing stalking horse, the Washington Legal Foundation, have been pushing for this move for years....
Tags: FDA, Drug Company, Federal Government, Government, Jim Edwards
Blog posts 2009-01-13
Drug Makers Gave Lobbyists an Xmas Gift -- Millions More to Lobby Obama Administration
A New Year will bring a new president, a new FDA chief, many new drug regulations, and, possibly, health insurance reform. Mindful of the ton of major drug brands that will go off-patent in 2009, drug companies have not rested in their lobbying efforts over generics and patent issues. They...
Tags: FDA, Vaccine, Administration, Drug Company, U.S. Congress, Pharmaceutical Company, Health Care, Drug, Teva, Biotech Drug, Biotechnology, Healthcare, Vertical Industries, Benefits, Enterprise Software, Software, Human Resources, Jim Edwards
Blog posts 2008-12-31